Vividion Therapeutics

Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery. Making accessible the broad set of proteins expressed in human cells, the company’s platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering synthetic and proteomic chemistry platforms to create therapeutics that will make a transformative difference in patients.

Vividion Therapeutics, established in 2013 and headquartered in United States, North America., specializes in investments across Biotechnology, Health Care, Wellness, Therapeutics. Their recent investments include Tavros Therapeutics. The highest investment round they participated in was $280.0M. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.